ImmuneBridge is a San Francisco biotech company building a first-in-class integrated screening and manufacturing platform for allogeneic cell therapies. The company screens and expands stem cells from multiple sources (umbilical cord blood, mobilized blood, bone marrow), uses high-throughput automated assays with machine-learning models to predict… - View it on GitHub